CXCL4 promoted the production of CD4⁺CD25⁺FOXP3⁺treg cells in mouse sepsis model through regulating STAT5/FOXP3 pathway

References

• Markwart R, Condotta SA, Requardt RP, et al. Immunosuppression after sepsis: systemic inflammation and sepsis induce a loss of Naïve T-cells but no enduring cell-autonomous defects in T-cell function. PloS One. 2014;9(12):e115094.
   PubMed Web of Science ®Google Scholar
• Reinhart K, Bauer M, Riedemann NC, et al. New approaches to sepsis: molecular diagnostics and biomarkers. Clin Microbiol Rev. 2012;25(4):609–634.
   PubMed Web of Science ®Google Scholar
• Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801–810.
   PubMed Web of Science ®Google Scholar
• Shen XF, Cao K, Jiang JP, et al. Neutrophil dysregulation during sepsis: an overview and update. J Cell Mol Med. 2017;21(9):1687–1697.
   PubMed Web of Science ®Google Scholar
• Wu HP, Chu CM, Kao KC, et al. High interleukin-10 expression in type 2 T helper cells in septic patients. Immunol Invest. 2017;46(4):385–394.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Narazaki M, Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014;6(10):a016295.
   PubMed Web of Science ®Google Scholar
• He Y, Xiao Y, Yang X, et al. SIRT6 inhibits TNF-α-induced inflammation of vascular adventitial fibroblasts through ROS and Akt signaling pathway. Exp Cell Res. 2017;357(1):88–97.
   PubMed Web of Science ®Google Scholar
• Jones SL, Ashton CM, Kiehne L, et al. Reductions in sepsis mortality and costs after design and implementation of a nurse-based early recognition and response program. HHS Public Access. 2015;41(11):483–491.
   Google Scholar
• Bonelli M, Göschl L, Blüml S, et al. CD4+Foxp3− T cells: a marker for lupus nephritis? Arthritis Res Ther. 2014;16(2):R104.
   PubMed Web of Science ®Google Scholar
• Baecher-Allan C, Brown JA, Freeman GJ, et al. CD4 + CD25high regulatory cells in human peripheral blood. J Immunol. 2001;167(3):1245–1253.
   PubMed Web of Science ®Google Scholar
• Bluestone JA, Tang Q, Sedwick CE. T regulatory cells in autoimmune diabetes: past challenges, future prospects. J Clin Immunol. 2008;28(6):677–684.
   PubMed Web of Science ®Google Scholar
• Schmidt A, Éliás S, Joshi RN, et al. In vitro differentiation of human CD4 + FOXP3+ induced regulatory T cells (iTregs) from Naïve CD4+ T cells using a TGF-β-containing protocol. 2016;2016(118):55015.
   Google Scholar
• Schmetterer KG, Neunkirchner A, Pickl WF. Naturally occurring regulatory T cells: markers, mechanisms, and manipulation. Faseb J. 2012;26(6):2253–2276.
   PubMed Web of Science ®Google Scholar
• Hadaschik EN, Enk AH. TGF-β1-induced regulatory T cells. Hum Immunol. 2015;76(8):561–564.
   PubMed Web of Science ®Google Scholar
• Leng FY, Liu JL, Liu ZJ, et al. Increased proportion of CD4 + CD25 + Foxp3 + regulatory T cells during early-stage sepsis in ICU patients. J Microbiol Immunol Infect. 2013;46(5):338–344.
   PubMedGoogle Scholar
• Nascimento DC, Alves-Filho JC, Fabiane SN, et al. Role of regulatory T cells in long-term immune dysfunction associated with severe sepsis. Crit Care Med. 2010;38(8):1718–1725.
   PubMed Web of Science ®Google Scholar
• Hiraki S, Ono S, Tsujimoto H, et al. Neutralization of interleukin-10 or transforming growth factor-β decreases the percentages of CD4+ CD25+ Foxp3+ regulatory T cells in septic mice, thereby leading to an improved survival . Surgery. 2012;151(2):313–322. Feb
   PubMed Web of Science ®Google Scholar
• Guillaume M, Anne-Lise D, Fabienne V, et al. Marked elevation of human circulating CD4 + CD25+ regulatory T cells in sepsis-induced immunoparalysis. Critical Care Medicine. 2003;31(7):2068–2071.
   PubMed Web of Science ®Google Scholar
• Linterman Michelle A, Denton AE. Treg cells and CTLA-4: the ball and chain of the germinal center response. Immunity. 2014;41(6):876–878.
   PubMed Web of Science ®Google Scholar
• Sojka DK, Huang YH, Fowell DJ. Mechanisms of regulatory T-cell suppression - a diverse arsenal for a moving target. Immunology. 2008;124(1):13–22.
   PubMed Web of Science ®Google Scholar
• Tomoyuki Y, Ayumi K, Motonao O, et al. Construction of self-recognizing regulatory T cells from conventional T cells by controlling CTLA-4 and IL-2 expression. Proc Natl Acad Sci USA. 2013;110(23):E2116–E2125.
   PubMed Web of Science ®Google Scholar
• Jain N, Nguyen H, Chambers C, et al. Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity. Proc Natl Acad Sci USA. 2010;107(4):1524–1528.
   PubMed Web of Science ®Google Scholar
• Inoue S, Bo L, Bian J, et al. Dose-dependent effect of anti-CTLA-4 on survival in sepsis. Shock. 2011;36(1):38–44.
   PubMed Web of Science ®Google Scholar
• Villarino A, Laurence A, Robinson GW, et al. Signal transducer and activator of transcription 5 (STAT5) paralog dose governs T cell effector and regulatory functions. elife. 2016;5:e08384.
   PubMed Web of Science ®Google Scholar
• Srahna M, Grunsven LA, Remacle JE, et al. CTLA-4 interacts with STAT5 and inhibits STAT5-mediated transcription. Immunology. 2006;117(3):396–401.
   PubMed Web of Science ®Google Scholar
• Burchill MA, Yang J, Vogtenhuber C, et al. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J Immunol. 2007;178(1):280–290.
   PubMed Web of Science ®Google Scholar
• Ma H, Gao W, Sun X, et al. STAT5 and TET2 cooperate to regulate FOXP3-TSDR demethylation in CD4+ T cells of patients with colorectal cancer. J Immunol Res. 2018;2018:6985031–6985038.
   PubMedGoogle Scholar
• Sinclair A, Park L, Shah M, et al. CXCR2 and CXCL4 regulate survival and self-renewal of hematopoietic stem/progenitor cells. Blood. 2016;128(3):371–383.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Gao J, Wang X, et al. CXCL4 mediates tumor regrowth after chemotherapy by suppression of antitumor immunity. Cancer Biol Ther. 2015;16(12):1775–1783.
   PubMed Web of Science ®Google Scholar
• Kasper B, Petersen F. Molecular pathways of platelet factor 4/CXCL4 signaling. Eur J Cell Biol. 2011;90(6–7):521–526.
   PubMed Web of Science ®Google Scholar
• Lasagni L, Francalanci M, Annunziato F, et al. An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J Exp Med. 2003;197(11):1537–1549.
   PubMed Web of Science ®Google Scholar
• Wang X, Zhao Z, Zhu K, et al. Effects of CXCL4/CXCR3 on the lipopolysaccharide‐induced injury in human umbilical vein endothelial cells. J Cell Physiol. 2019;234(12):22378–22385.
   PubMed Web of Science ®Google Scholar
• Liu CY, Battaglia M, Lee SH, et al. Platelet factor 4 differentially modulates CD4 + CD25+ (Regulatory) versus CD4 + CD25- (Nonregulatory) T cells. J Immunol. 2005;174(5):2680–2686.
   PubMed Web of Science ®Google Scholar
• Matics TJ, Sanchez-Pinto LN. Adaptation and validation of a pediatric sequential organ failure assessment score and evaluation of the sepsis-3 definitions in critically Ill children. JAMA Pediatr. 2017;171(10):e172352.
   PubMed Web of Science ®Google Scholar
• Ka W, Ae B, Ih C. Sepsis and septic shock–a review of laboratory models and a proposal. J Surg Res. 1980;29(2):189–201.
   PubMed Web of Science ®Google Scholar
• Toscano MG, Ganea D, Gamero AM. Cecal ligation puncture procedure. J Vis Exp. 2011;7(51):2860.
   Google Scholar
• Chaudhry H, Zhou J, Zhong Y, et al. Role of cytokines as a double-edged sword in sepsis. HHS Public Access. 2013;27(6):669–684.
   Google Scholar
• Rittirsch D, Flierl MA, Ward PA. Harmful molecular mechanisms in sepsis. Nat Rev Immunol. 2008 ;8(10):776–787.
   PubMed Web of Science ®Google Scholar
• Ma L, Zhao P, Jiang Z, et al. Imbalance of different types of CD4(+) forkhead box protein 3 (FoxP3)(+) T cells in patients with new-onset systemic lupus erythematosus. Clin Exp Immunol. 2013 ;174(3):345–355. Dec
   PubMed Web of Science ®Google Scholar
• Scumpia PO, Delano MJ, Kelly KM, et al. Increased natural CD4 + CD25+ regulatory T cells and their suppressor activity do not contribute to mortality in murine polymicrobial sepsis. J Immunol. 2006;177(11):7943–7949.
   PubMed Web of Science ®Google Scholar
• Passerini L, Allan SE, Battaglia M, et al. STAT5-signaling cytokines regulate the expression of FOXP3 in CD4 + CD25+ regulatory T cells and CD4 + CD25- effector T cells . Int Immunol. 2008;20(3):421–431.
   PubMed Web of Science ®Google Scholar
• Mao QF, Shang-Guan ZF, Chen HL, et al. Immunoregulatory role of IL-2/STAT5/CD4 + CD25 + Foxp3 Treg pathway in the pathogenesis of chronic osteomyelitis. Ann Transl Med. 2019 ;7(16):384–384. Aug
   PubMed Web of Science ®Google Scholar
• Zheng Y, Wang Z, Deng L, et al. Modulation of STAT3 and STAT5 activity rectifies the imbalance of Th17 and Treg cells in patients with acute coronary syndrome. Clin Immunol. 2015;157(1):65–77.
   PubMed Web of Science ®Google Scholar